Total Payments
$933.32
2024 Payments
$50.91
Companies
10
Transactions
25
Medicare Patients
22,389
Medicare Billing
$2.6M
Payment Breakdown by Category
Food & Beverage$583.32 (62.5%)
Other$350.00 (37.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $583.32 | 24 | 62.5% |
| Honoraria | $350.00 | 1 | 37.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biofrontera Inc. | $601.10 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $84.58 | 4 | $0 (2019) |
| Lilly USA, LLC | $57.05 | 3 | $0 (2022) |
| GENZYME CORPORATION | $39.10 | 1 | $0 (2023) |
| Sun Pharmaceutical Industries Inc. | $34.37 | 2 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $31.21 | 1 | $0 (2024) |
| Amgen Inc. | $27.91 | 1 | $0 (2023) |
| UCB, Inc. | $25.76 | 1 | $0 (2022) |
| DUSA Pharmaceuticals, Inc. | $17.93 | 1 | $0 (2018) |
| iCAD, Inc | $14.31 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50.91 | 2 | Regeneron Healthcare Solutions, Inc. ($31.21) |
| 2023 | $67.01 | 2 | GENZYME CORPORATION ($39.10) |
| 2022 | $85.07 | 5 | UCB, Inc. ($25.76) |
| 2020 | $53.10 | 3 | Sun Pharmaceutical Industries Inc. ($34.37) |
| 2019 | $49.27 | 3 | Biofrontera Inc. ($27.87) |
| 2018 | $561.00 | 6 | Biofrontera Inc. ($498.84) |
| 2017 | $66.96 | 4 | Lilly USA, LLC ($31.55) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/24/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $19.70 | General |
| Category: DERMATOLOGY | ||||||
| 03/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/19/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $39.10 | General |
| Category: Immunology | ||||||
| 11/20/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: Inflammation | ||||||
| 10/31/2022 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $16.67 | General |
| Category: DERMATOLOGY | ||||||
| 07/27/2022 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $2.83 | General |
| Category: DERMATOLOGY | ||||||
| 06/21/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Immunology | ||||||
| 06/13/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Immunology | ||||||
| 05/25/2022 | iCAD, Inc | AXXENT SURFACE CONTROLLER (Device) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Oncology | ||||||
| 03/12/2020 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $18.73 | General |
| Category: DERMATOLOGY | ||||||
| 02/13/2020 | Sun Pharmaceutical Industries Inc. | LEVULAN KERASTICK (Drug), BLU-U | Food and Beverage | Cash or cash equivalent | $11.97 | General |
| Category: Dermatology | ||||||
| 01/14/2020 | Sun Pharmaceutical Industries Inc. | BLU-U (Device), LEVULAN KERASTICK | Food and Beverage | Cash or cash equivalent | $22.40 | General |
| Category: Dermatology | ||||||
| 11/26/2019 | Biofrontera Inc. | Ameluz (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $15.99 | General |
| Category: Dermatology | ||||||
| 08/28/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: DERMATOLOGY | ||||||
| 08/27/2019 | Biofrontera Inc. | Ameluz (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $11.88 | General |
| Category: Dermatology | ||||||
| 07/31/2018 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: DERMATOLOGY | ||||||
| 03/30/2018 | Biofrontera Inc. | Ameluz (Drug), BF-RhodoLED | Honoraria | Cash or cash equivalent | $350.00 | General |
| Category: Dermatology | ||||||
| 03/05/2018 | Biofrontera Inc. | Ameluz (Drug), BF-RhodoLED | Food and Beverage | Cash or cash equivalent | $130.01 | General |
| Category: Dermatology | ||||||
| 01/22/2018 | Biofrontera Inc. | Ameluz (Drug), BF-RhodoLED | Food and Beverage | Cash or cash equivalent | $18.83 | General |
| Category: Dermatology | ||||||
| 01/10/2018 | DUSA Pharmaceuticals, Inc. | BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 (Device), Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20% | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Dermatology | ||||||
| 01/03/2018 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: DERMATOLOGY | ||||||
| 09/19/2017 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Immunology | ||||||
| 08/29/2017 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: DERMATOLOGY | ||||||
| 03/15/2017 | Biofrontera Inc. | Ameluz (Drug), BF-RhodoLED | Food and Beverage | Cash or cash equivalent | $16.46 | General |
| Category: Dermatology | ||||||
| 02/08/2017 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 5,482 | 16,385 | $1.2M | $632,992 |
| 2022 | 41 | 5,437 | 16,544 | $1.3M | $635,899 |
| 2021 | 43 | 5,824 | 18,769 | $1.3M | $682,085 |
| 2020 | 47 | 5,646 | 18,257 | $1.3M | $633,861 |
Total Patients
22,389
Total Services
69,955
Medicare Billing
$2.6M
Procedure Codes
172
All Medicare Procedures & Services
172 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 1,361 | 3,475 | $313,086 | $192,770 | 61.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 634 | 1,256 | $171,874 | $86,285 | 50.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 534 | 824 | $126,863 | $60,138 | 47.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 255 | 396 | $76,638 | $38,054 | 49.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 315 | 672 | $51,393 | $27,266 | 53.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 397 | 701 | $71,563 | $24,487 | 34.2% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 158 | 352 | $48,783 | $22,640 | 46.4% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 207 | 789 | $53,352 | $17,457 | 32.7% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 26 | 30 | $30,999 | $16,565 | 53.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 134 | 174 | $29,895 | $14,884 | 49.8% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 24 | 35 | $14,285 | $10,729 | 75.1% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 33 | 43 | $18,030 | $9,355 | 51.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 53 | 70 | $19,104 | $9,184 | 48.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 244 | 302 | $23,412 | $8,244 | 35.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 283 | 1,511 | $14,991 | $7,951 | 53.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 41 | 44 | $16,450 | $7,645 | 46.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 141 | 171 | $14,655 | $7,412 | 50.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 75 | 75 | $12,895 | $6,467 | 50.2% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 17 | 19 | $11,888 | $6,369 | 53.6% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 24 | 4,825 | $11,951 | $6,263 | 52.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 51 | 61 | $11,673 | $5,998 | 51.4% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 53 | 57 | $10,597 | $5,005 | 47.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $9,913 | $4,907 | 49.5% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 41 | 41 | $8,574 | $4,344 | 50.7% |
| 11106 | Incision biopsy, first skin growth | Office | 2023 | 28 | 32 | $7,576 | $3,763 | 49.7% |
About Dr. Russel Glaun, MD
Dr. Russel Glaun, MD is a Dermatopathology healthcare provider based in Boca Raton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265468417.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Russel Glaun, MD has received a total of $933.32 in payments from pharmaceutical and medical device companies, with $50.91 received in 2024. These payments were reported across 25 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($583.32).
As a Medicare-enrolled provider, Glaun has provided services to 22,389 Medicare beneficiaries, totaling 69,955 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 172 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Other Specialties Dermatology
- Location Boca Raton, FL
- Active Since 06/22/2006
- Last Updated 04/26/2017
- Taxonomy Code 207ND0900X
- Entity Type Individual
- NPI Number 1265468417
Products in Payments
- Ameluz (Drug) $543.17
- COSENTYX (Biological) $84.58
- DUPIXENT (Biological) $70.31
- AMELUZ (Drug) $57.93
- TALTZ (Drug) $57.05
- Otezla (Drug) $27.91
- Cimzia (Drug) $25.76
- BLU-U (Device) $22.40
- BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 (Device) $17.93
- AXXENT SURFACE CONTROLLER (Device) $14.31
- LEVULAN KERASTICK (Drug) $11.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.